Search Results 881-890 of 15967 for Residual
Progressive OR residual disease. Residual measurable disease immediately after surgery without requirement for progression; For Grade I disease, progression ...
The purpose of this study is to determine the safety and feasibility of complete outpatient blinatumomab administration for subjects with minimal residual ...
Modifiable Risk Factors and Residual Risk Following Coronary Revascularization: Insights From a Regionalized Dedicated Follow-Up Clinic. Mayo Clin Proc ...
imb loss, Phantom pain, Residual limb pain. Show more areas of focus for F. Clay Smither, M.D.. Brittany Snider, D.O.. Physiatrist.
Residual Tumor on Wide Excisional Margins After Treatment of Invasive Melanoma. Anticancer Res. 2020 Feb; 40 (2):1059-1063. View PubMed; Bellomo D, Arias ...
Mylan Blomquist: Imaging Residual Brain Tumor Cells to Improve ...
... residual untreated lesions remaining. Such patients are eligible for enrollment on this study providing that at least one residual (i.e., non-SRS-treated or ...
Currently compromised skin integrity on residual limb. Note: Other protocol defined Inclusion/Exclusion Criteria may apply. Eligibility last updated 11/12 ...
Residual or progressive lesions after surgery if asymptomatic;; Patients who have had prior whole-brain radiotherapy (WBRT) and/or SRS and then whose lesions ...
Known allergies, hypersensitivity, or intolerance to the excipients of cilta-cel OOS including dimethyl sulfoxide (DMSO), dextran 40, or residual kanamycin per ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.